AnthonyBottiMD

Medical Director, LSG Infusion Services

Dr. Botti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Office
349 E Northfield Rd
Suite 200
Livingston, NJ 07039
Phone+1 973-597-0900
Is this information wrong?

Having fulfilled a 40-year career in hematology-oncology, I have moved on to a medical director position at LSG Infusion Services in Livingston, NJ. At LSG Infusions, I supervise infusion care and provide chair-side assistance when necessary. We are the future of outpatient infusion care.

LSG Infusion Services | Infusion North Jersey | 349 E. Northfield Ave, Suite 200

At LSG Infusion Services the emphasis is on personalized care and close coordination with your referring physician.

Hodgkin's lymphoma, Anemias, Myelodysplastic syndromes , Myeloproliferative disease, Bone marrow failure syndromes, Myeloproliferative disorders, Leukemia, Anemia

Long Island Coll Hosp1988
One Brooklyn Health System/Interfaith Medical CenterResidency, Internal Medicine, 1982 - 1985
Universidad de Navarra Faculty of MedicineClass of 1982
Wagner CollegeMS, Biomedical Sciences, 1978
Catholic University of AmericaBA, Biology, 1976

CMS Meaningful Use Stage 1 Certification ChartMaker Medical Suite EHR, STI Computer Services, Inc., 2012-2013
Top MD Consumers Checkbook

PubMed

6 citations
JAK2V617F mutation and myeloproliferative malignancy in a patient with Type 1 Gaucher disease.
Bryn D. Webb, Neal J. Weinreb, Anthony C. Botti, Brian Kirmse, Manisha Balwani> ;Blood Cells, Molecules & Diseases. 2011 Jan 15

Journal Articles

JAK2V617F Mutation and Myeloproliferative Malignancy in a Patient with Type I Gaucher Disease
Webb BD, Weinreb NJ, Botti AC, Kirmse BM, Balwani M, Blood Cells Mol Dis, 1/1/2011
The Molecular Biology of Acute Lymphoblastic Leukemia
Botti AC and Verma RS, Anti-Cancer Research, 1/1/1990
Lymphoma and the Acquired Immunodeficiency Syndrome: Cytogenetic and Molecular Correlates
Botti AC, Diamond GR and Verma RS, European Journal of Cancer and Clinical Oncology, 1/1/1988
Thrombotic Thrombocytopenic Purpura in a Patient Who Subsequently Developed the Acquired Immunodeficiency Syndrome
Botti AC, Hyde P, and Dipillo F, Annals of Internal Medicine, 1/1/1988
Clonal Expansion after Bone Marrow Transplantation in Patient with Chronic Myelogenous Leukemia
Macera MJ, Botti AC, Verma RS, Coleman M and Thomas ED, BLUT, 1/1/1988
A New Translocation Involving Chromosomes 8 and 9 in a So-called Ph-negative Chronic Myelogenous Leukemia
Botti AC, Macere MJ and Verma RS, Cancer Genetics and Cytogenetics, 1/1/1988
Join now to see all

Abstracts/Posters

Recombinant Human Interferon-alpha Safely Induces Remission in the Essential Thrombocytosis of the Elderly
Botti AC, Sangosse M, Abdelmessiah N and Ong E, 33rd Annual Meeting of the American Society of Hematology, Denver, Colorado, 1/1/1991
Fatal B-19 Parvovirus Infection in Two Patients Doubly Heterozygous for Hemoglobins 'S' and 'C'
Botti AC, Gascon P, Kanuga D and Nayak S, 32nd Annual Meeting of the American Society of Hematology, Boston, Massachussetts, 1/1/1990
Coexistent Hodgkin Lymphoma & Metastatic ca in a HIV(+) Patient
Botti AC and Kanuga D, 31st Annual Meeting of ASH, Atlanta, Georgia, 1/1/1989
Emergence of Complex Chromosomal Abnormalities after Bone Marrow Transplantation in a Patient with Chronic Myelogenous Leukemia
Botti AC, Macera MJ, Verma RS, Coleman M and Thomas ED, 39th Annual Meeting of the American Society of Human Genetics, New Orleans, Louisiana, 1/1/1988
Molecular Characterization of a Masked Ph-1 Chromosome with a Rare Translocation in Chronic Myelogenous Leukemia
Botti AC, Silver RT, Macera MJ and Verma RS, 29th Annual Meeting of the American Society of Hematology, Washington, D.C., 1/1/1987
Leukapheresis Safely Maintained Acceptable Peripheral Blood Counts in a Pregnant Woman with Chronic Myelogenous Leukemia
Botti AC, Kulpa J and Ramirez G, 29th Annual Meeting of the American Society of Hematology, Washington, D.C., 1/1/1987
Join now to see all